Crovalimab: a new era in paroxysmal nocturnal hemoglobinuria management. [PDF]
Waheed A +6 more
europepmc +1 more source
HSD51 Evaluation of the Healthcare System Burden Associated With Intravenous Treatment for Paroxysmal Nocturnal Hemoglobinuria [PDF]
BP Mulherin +11 more
openalex +1 more source
What are the most important quality of life domains for patients with aplastic anemia and paroxysmal nocturnal hemoglobinuria? [PDF]
Taylor KJ +9 more
europepmc +1 more source
Safety, Efficacy, and Patient-Reported Outcomes From a Phase 2 Randomized Trial of Pozelimab and Cemdisiran Combination in Patients With Paroxysmal Nocturnal Hemoglobinuria. [PDF]
Jang JH +12 more
europepmc +1 more source
Managing transient immune complex reactions in patients with paroxysmal nocturnal hemoglobinuria: clinical observations from the COMMODORE 1 and 2 studies. [PDF]
Kulasekararaj AG +9 more
europepmc +1 more source
FDA approval of crovalimab: a milestone in paroxysmal nocturnal hemoglobinuria treatment. [PDF]
Anwar D +6 more
europepmc +1 more source
Real-World Prevalence and Outcomes of Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with C5 Inhibitors in the US: A Retrospective Claims Database Analysis. [PDF]
Tantravahi SK +9 more
europepmc +1 more source
Somatic mutations in Brazilian patients with paroxysmal nocturnal hemoglobinuria: a comprehensive analysis. [PDF]
Eiko Yamakawa P +12 more
europepmc +1 more source
Dose Adjustments of Pegcetacoplan in a Patient With Paroxysmal Nocturnal Hemoglobinuria Undergoing Surgery: A Case Report. [PDF]
Vara Pampliega M +2 more
europepmc +1 more source

